In-Licensing

Our in-licensing program identifies and evaluates biomarker opportunities that address unmet needs in the areas of cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases and psychiatric disorders. These opportunities come from a variety of institutions (academic centers, research clinics, discovery/tool companies and pharma/biotech companies) or independent inventors (physicians and scientists). Pathway Diagnostics has proven to be a value-added partner for our licensors by investing resources that are integral components for rapid development and commercialization of a clinical diagnostic. Our key components of diligence (patentability, freedom-to-operate landscape), intellectual property protection (patent, trademark), technical development (analytical validation, clinical verification), business development and product promotion help ensure a long product life cycle. As a vital link to the licensor and commercial partners, we are committed to licensing biomarkers that bring value to all involved business, research and clinical parties.

Biomarker Success Features:

• Actionable information for clinicians - fulfill an unmet medical need
• Results that support early diagnosis, response to therapy or patient monitoring
• Solid patent position, free to operate
• Viable assay format for clinical laboratories